Back to GetFilings.com



 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

ý

 

QUARTERLY  REPORT  PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES  EXCHANGE ACT OF 1934

 

 

For the quarterly period ended June 30, 2002

OR

 

o

 

TRANSITION  REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES  EXCHANGE ACT OF 1934

 

 

For the transition period from          to

 

Commission file number: 000-28347

 

TULARIK INC.

(Exact name of Registrant as specified in its charter)

 

Delaware

 

94-3148800

(State or other jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

 

 

Two Corporate Drive, South San Francisco, California

 

94080

(Address of principal executive offices)

 

(Zip code)

 

 

 

(650) 825-7000

(Registrant’s telephone number including area code)

 

 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of 1934  during  the  preceding  12 months  (or for such  shorter  period  that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý            No o

 

As of July 31, 2002, 50,786,472 shares of the Registrant’s common stock were outstanding.

 



 

TULARIK INC.

INDEX

 

PART I.  FINANCIAL INFORMATION

 

Item 1. Unaudited Financial Statements

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results Of Operations

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

 

Part II.  OTHER INFORMATION

 

Item 5.  Other Information

 

Item 6. Exhibits and Reports on Form 8-K

 

Signatures

 

2



 

PART I.  FINANCIAL INFORMATION

 

Item 1.    Unaudited Financial Statements

 

Condensed Consolidated Balance Sheets

(Unaudited)

(In thousands, except share and per share data)

 

 

 

June 30,

 

December 31,

 

ASSETS

 

2002

 

2001 (1)

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

82,713

 

$

109,392

 

Short-term investments

 

77,817

 

107,197

 

Prepaid expenses and other current assets

 

5,720

 

6,832

 

Total current assets

 

166,250

 

223,421

 

 

 

 

 

 

 

Property and equipment, net

 

33,924

 

34,011

 

Other investments

 

45,447

 

25,337

 

Restricted investments

 

4,273

 

2,008

 

Other assets

 

5,225

 

5,405

 

Goodwill

 

3,100

 

3,100

 

Total assets

 

$

258,219

 

$

293,282

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

3,104

 

$

4,855

 

Accrued compensation and related liabilities

 

2,948

 

3,039

 

Accrued liabilities

 

6,342

 

5,388

 

Current portion of long-term debt and capital lease  obligations

 

7,020

 

6,685

 

Deferred revenue

 

19,387

 

14,211

 

Total current liabilities

 

38,801

 

34,178

 

 

 

 

 

 

 

Long-term debt and capital lease obligations

 

10,042

 

10,801

 

Long-term portion of deferred revenue

 

12,256

 

12,083

 

Other non-current liabilities

 

2,470

 

1,999

 

Total liabilities

 

63,569

 

59,061

 

Commitments

 

 

 

 

 

Minority interest in Cumbre Inc.

 

26,250

 

26,250

 

Stockholders' equity:

 

 

 

 

 

Convertible preferred stock; $.001 par value; 5,000,000 shares authorized; none issued and outstanding

 

 

 

Common stock; $.001 par value; 145,000,000 shares authorized; 50,625,971 and 49,890,865 shares issued and outstanding at June 30, 2002 and December 31, 2001, respectively

 

51

 

50

 

Additional paid-in capital

 

393,165

 

387,484

 

Notes receivable from stockholders

 

(106

)

(230

)

Deferred compensation, net

 

(157

)

(351

)

Accumulated other comprehensive (loss) income

 

(411

)

239

 

Accumulated deficit

 

(224,142

)

(179,221

)

Total stockholders’ equity

 

168,400

 

207,971

 

Total liabilities and stockholders’ equity

 

$

258,219

 

$

293,282

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 


(1) The condensed consolidated balance sheet at December 31, 2001 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.

 

3



Condensed Consolidated Statements of Operations

(Unaudited)

(In thousands, except share and per share data)

 

 

 

Three months ended

 

Six months ended

 

 

 

June 30,

 

June 30,

 

 

 

2002

 

2001

 

2002

 

2001

 

Revenue:

 

 

 

 

 

 

 

 

 

Collaborative research and development

 

$

6,575

 

$

8,315

 

$

12,751

 

$

15,356

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Research and development

 

28,580

 

21,777

 

53,824

 

40,444

 

General and administrative

 

3,288

 

3,374

 

6,002

 

6,226

 

 

 

31,868

 

25,151

 

59,826

 

46,670

 

Loss from operations

 

(25,293

)

(16,836

)

(47,075

)

(31,314

)

Interest and other income

 

1,329

 

3,370

 

2,948

 

8,803

 

Realized gains on sale of securities

 

 

1,898

 

 

2,162

 

Interest expense

 

(402

)

(368

)

(794

)

(759

)

Net loss

 

$

(24,366

)

$

(11,936

)

$

(44,921

)

$

(21,108

)

 

 

 

 

 

 

 

 

 

 

Basic and diluted net loss per share

 

$

(0.48

)

$

(0.25

)

$

(0.89

)

$

(0.44

)